NCT06980350View on ClinicalTrials.gov

Proposal of a Novel Model for Identifying Complete Response in dMMR Colon Cancer Following Neoadjuvant Immunotherapy

CompletedOBSERVATIONAL

Enrollment

156

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

June 30, 2023

Study Completion Date

December 30, 2024

Conditions

Colorectal Cancer

Interventions

DRUG

PD-1 Inhibitors

Patients received at least two doses of anti-PD-1 immunotherapy in a neoadjuvant setting.

Trial Locations (1)

510060

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER

NCT06980350 - Proposal of a Novel Model for Identifying Complete Response in dMMR Colon Cancer Following Neoadjuvant Immunotherapy | Biotech Hunter | Biotech Hunter